1. Home
  2. GLU vs GNLX Comparison

GLU vs GNLX Comparison

Compare GLU & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLU
  • GNLX
  • Stock Information
  • Founded
  • GLU 2004
  • GNLX 2001
  • Country
  • GLU United States
  • GNLX United States
  • Employees
  • GLU N/A
  • GNLX N/A
  • Industry
  • GLU Finance/Investors Services
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GLU Finance
  • GNLX Health Care
  • Exchange
  • GLU Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • GLU 92.2M
  • GNLX 85.0M
  • IPO Year
  • GLU N/A
  • GNLX 2023
  • Fundamental
  • Price
  • GLU $15.56
  • GNLX $4.31
  • Analyst Decision
  • GLU
  • GNLX Strong Buy
  • Analyst Count
  • GLU 0
  • GNLX 4
  • Target Price
  • GLU N/A
  • GNLX $18.25
  • AVG Volume (30 Days)
  • GLU 12.4K
  • GNLX 314.9K
  • Earning Date
  • GLU 01-01-0001
  • GNLX 03-31-2025
  • Dividend Yield
  • GLU 8.60%
  • GNLX N/A
  • EPS Growth
  • GLU N/A
  • GNLX N/A
  • EPS
  • GLU 0.62
  • GNLX N/A
  • Revenue
  • GLU N/A
  • GNLX $8,000.00
  • Revenue This Year
  • GLU N/A
  • GNLX N/A
  • Revenue Next Year
  • GLU N/A
  • GNLX N/A
  • P/E Ratio
  • GLU $22.50
  • GNLX N/A
  • Revenue Growth
  • GLU N/A
  • GNLX N/A
  • 52 Week Low
  • GLU $11.61
  • GNLX $1.60
  • 52 Week High
  • GLU $15.40
  • GNLX $9.82
  • Technical
  • Relative Strength Index (RSI)
  • GLU 57.11
  • GNLX 75.11
  • Support Level
  • GLU $15.40
  • GNLX $3.20
  • Resistance Level
  • GLU $15.68
  • GNLX $4.23
  • Average True Range (ATR)
  • GLU 0.31
  • GNLX 0.56
  • MACD
  • GLU 0.10
  • GNLX 0.10
  • Stochastic Oscillator
  • GLU 86.79
  • GNLX 95.73

About GLU Gabelli Global Utility of Beneficial Ownership

Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.

Share on Social Networks: